PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer
Prescription Drug User Fee Act (PDUFA) date set for August 16, 2020. MADRID and DUBLIN, Feb. 17, 2020 -- (Healthcare Sales & Marketing Network) -- PharmaMar (MSE:PHM) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announce that the U.S. Food and Drug Admi... Biopharmaceuticals, Oncology, FDA Jazz Pharmaceuticals, PharmaMar , lurbinectedin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 17, 2020 Category: Pharmaceuticals Source Type: news

Heart condition can be cured with a quick blast of lung cancer therapy
Ventricular tachycardia is a major cause of sudden cardiac death, and kills more than 100,000 in the UK every year. Tests show the abnormal rhythm can be corrected with a pain-free blast of radiotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2020 Category: Consumer Health News Source Type: news

Thoracic Radiation May Increase Fatigue, Dyspnea in Short Term
In patients with lung cancer or lymphoma, increase in heart dose tied to decrease in physical activity (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 14, 2020 Category: Cancer & Oncology Tags: Cardiology, Gynecology, Oncology, Pulmonology, Radiology, Conference News, Source Type: news

CT lung screening risk models optimize nodule management
Risk prediction models can differentiate between benign and malignant nodules...Read more on AuntMinnie.comRelated Reading: Mobile CT improves access to lung cancer screening Findings from NELSON trial affirm benefits of CT lung screening Life expectancy model refines CT lung screening criteria Risk model improves accuracy of CT lung cancer screening Risk model predicts malignancy of lung nodules on CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 14, 2020 Category: Radiology Source Type: news

Beagles can "sniff out" lung cancer more accurately than "advanced technology"
(Natural News) Lung cancer is the second most common type of cancer and the leading cause of cancer death in both men and women in the United States. There are several types of lung cancer, but non-small cell (NSCLC) is the most common form. Since NSCLC is so deadly, early detection is vital if a... (Source: NaturalNews.com)
Source: NaturalNews.com - February 14, 2020 Category: Consumer Health News Source Type: news

China National Medical Products Administration grants approval of Roche ’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer
Basel, 14 February 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that China National Medical Products Administration (NMPA) has approved Tecentriq® (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).“Small cell lung cancer is an area of major unmet need in China and one that has seen limited advances until now,” said Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development. “This approval makes Tecentriq the first cancer immunotherapy...
Source: Roche Media News - February 14, 2020 Category: Pharmaceuticals Source Type: news

China National Medical Products Administration grants approval of Roche ’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer
Basel, 14 February 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that China National Medical Products Administration (NMPA) has approved Tecentriq® (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).“Small cell lung cancer is an area of major unmet need in China and one that has seen limited advances until now,” said Levi Garraway, M.D., Ph.D., Chief Medical Officer and Head of Global Product Development. “This approval makes Tecentriq the first cancer immunotherapy...
Source: Roche Investor Update - February 14, 2020 Category: Pharmaceuticals Source Type: news

Radiation therapy to heart can worsen fatigue, shortness of breath in cancer patients
(American College of Cardiology) Radiation doses to the heart that occur during radiation therapy treatments for lung cancer, breast cancer and lymphoma can increase fatigue, cause difficulty breathing and lower capacity for physical activity in patients with cancer, according to research presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient course. The course examines new science and best practices in assessing, diagnosing and treating the unique cardiovascular concerns of patients with cancer and/or those requiring survivorship care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Scientists have identified protein involved in progression of lung cancer and melanoma
(Far Eastern Federal University) Scientists from Far Eastern Federal University (FEFU, Russia), University of Geneva (Switzerland), Minjiang University, and Fuzhou University (China) pointed out WDR74 protein playing an important role in lung cancer and melanoma primary tumors/metastases progression. During the research, the artificially gained WDR74 function brought about a high activity in cancer cells. However, when the function had been dropped cells failed to metastasize becoming more vulnerable to chemotherapy. Related articles are published in Cancer Letters and Oncogene. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 14, 2020 Category: Cancer & Oncology Source Type: news

More Lung Cancer Patients Presenting With Cough, Dyspnea
Findings based on analysis of index symptoms of U.K. patients from 2000 to 2017 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 13, 2020 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Oncology, Pulmonology, Journal, Source Type: news

More Lung Cancer Patients Presenting With Cough, Dyspnea
THURSDAY, Feb. 13, 2020 -- The proportion of lung cancer patients with an index symptom of cough or shortness of breath has increased over time, according to a study published online Jan. 27 in the British Journal of General Practice. Sarah... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 13, 2020 Category: Pharmaceuticals Source Type: news

Kenya: The Little-Known Gas in Your Home Causing Lung Cancer
[Nation] Cancer is the third-leading cause of death in Kenya. The government introduced the Cancer Prevention and Control Act 2012 and the National Cancer Control Strategy 2017-2022, aimed at creating awareness on routine testing and early treatment besides prevention and control. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 13, 2020 Category: African Health Source Type: news

Lung Cancer Mortality Suggested to be Significantly Lower with Volume CT
Among participants who were current or former smokers, the NELSON trial found that volume CT screening enabled a significant reduction of harms without jeopardizing favorable outcomes. (Source: CancerNetwork)
Source: CancerNetwork - February 13, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Synchronous Bilateral Lung Cancer With Discordant Histology
Medical oncologsts discuss the case of a 70-year old woman with synchronous multiple primary lung cancer. (Source: CancerNetwork)
Source: CancerNetwork - February 13, 2020 Category: Cancer & Oncology Authors: Mehmet Sitki Copur, MD, FACP, Rudy P. Lackner, MD, Whitney Wedel, MD, Nikki Lintel, MD, Matthew Stritt, MD, Kalpesh Ganatra, MD Source Type: news

Mobile CT improves access to lung cancer screening
A mobile CT unit in North Carolina is bringing lung cancer screening directly...Read more on AuntMinnie.comRelated Reading: Participation in CT lung screening reaches new heights Stroke care looks skyward with new mobile CT program Mobile CT unit boosts efficiency of stroke triage Demographic factors limit access to CT lung screening CT lung screening isn't reaching areas that need it most (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2020 Category: Radiology Source Type: news

Alternative to Alimta Coming for Mesothelioma Patients
The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant mesothelioma and advanced stage non-small cell lung cancer. The approval will allow oncologists to offer an alternative to Alimta, which today is considered standard pemetrexed and manufactured by Eli Lilly and Company. The chemotherapy drug is designed to block DNA replication and cell division. However, Pemfexy will not be available until February 2022. The FDA approval is limited to pleural mesothelioma patients whose disease is unresectable. Pemfexy is produced by Eagle Pharm...
Source: Asbestos and Mesothelioma News - February 12, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
Novartis announced that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) New Drug Application (NDA). Capmatinib is a MET inhibitor being evaluated as a treatment for first-line and previously treated patients with locally advanced or metastatic MET exon 14 skipping (METex14) mutated non-small cell lung cancer (NSCLC)(1). (Source: World Pharma News)
Source: World Pharma News - February 12, 2020 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Don ’t treat shortness of breath as trivial, GPs urged
It ’s a strong indicator of future serious ill health and early death, say researchers Related items fromOnMedica Illness poorly managed in those with learning disability Doctors warn of ‘feather duvet lung’ Road traffic pollution raises lung cancer risk NICE issues guidelines on neurological conditions UK asbestos regulations slammed (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 12, 2020 Category: UK Health Source Type: news

Lung cancer symptoms: A sign of the deadly disease in the face ‘you might not recognise’
LUNG cancer signs and symptoms don't usually show in the early stages, but as the condition progresses they may become more apparent. One sign to look out for can appear in the face, but a lung cancer charity says it's one "you might not recognise". (Source: Daily Express - Health)
Source: Daily Express - Health - February 11, 2020 Category: Consumer Health News Source Type: news

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review
FDA Priority Review for capmatinib based on Phase II data in first-line and previously treated patients with MET exon 14 skipping (METex14) mutated advanced non-small cell lung cancer (NSCLC)(1) Substantial unmet need exists among patients with METex14 ... Biopharmaceuticals, Oncology Novartis, capmatinib, METex14, NSCLC, lung cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 11, 2020 Category: Pharmaceuticals Source Type: news

Novartis lung cancer drug gets priority U.S. review
Novartis has won fast-track U.S. regulatory review for capmatinib (INC280) in a hard-to-treat form of lung cancer, the Swiss drugmaker said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Grants Priority Review to Capmatinib for Non-Small Cell Lung Cancer
The FDA granted a priority review to capmatinib, a MET inhibitor being analyzed for the first-line treatment of previously treated patients with METex14-mutated advanced NSCLC. (Source: CancerNetwork)
Source: CancerNetwork - February 11, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

New connections: Targeted treatment options for SCLC
Various studies reveal how we might effectively treat small cell lung cancer. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - February 11, 2020 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Summary report on small cell lung cancer research points to progress and challenges
(International Association for the Study of Lung Cancer) In 2017, a group of lung cancer experts posed the question: 'Can recent advances in tumor biology that have led to progress treating non-small cell lung cancer translate into improved outcomes for small cell lung cancer?'According to an article " New Approaches to Small Cell Lung Cancer Therapy : From the Laboratory to the Clinic, " published in the February issue of the Journal of Thoracic Oncology, the answer is " yes. " (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 10, 2020 Category: Cancer & Oncology Source Type: news

FDA Approves Pemetrexed for Injection for Nonsquamous Non-Small Cell Lung Cancer
The agency granted full approval to pemetrexed for injection (Pemfexy), a liquid injection and branded alternative to Alimta, for nonsquamous NSCLC. (Source: CancerNetwork)
Source: CancerNetwork - February 10, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news

Reducing variation in lung cancer care
The UK Lung Cancer Coalition has published advice for clinicians, commissioners and policy-makers to help ensure that consistent and equitable treatment and care options are being offered to patients who present with similar profiles, regardless of where they live. (Source: NHS Networks)
Source: NHS Networks - February 10, 2020 Category: UK Health Source Type: news

Feb 7 2020 This Week in Cardiology Feb 7 2020 This Week in Cardiology
TheNEJM retraction, TAVR 5-year results, ICD selection, long QT reversals, and lung cancer screening are the topics discussed by John Mandrola, MD in this week's podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 7, 2020 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Combined drug treatment for lung cancer and secondary tumors
(Kanazawa University) Researchers at Kanazawa University report in the Journal of Thoracic Oncology a promising novel approach for a combined treatment of the most common type of lung cancer and associated secondary cancers in the central nervous system. The approach lies in combining two cancer drugs, with one compensating for a resistance side effect of the other. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2020 Category: Cancer & Oncology Source Type: news

Screening Mammography Visits Useful for Smoking Cessation, Lung Cancer Screening Referrals Screening Mammography Visits Useful for Smoking Cessation, Lung Cancer Screening Referrals
Screening mammography visits offer opportunities to engage smokers with tobacco cessation services and, if appropriate, lung cancer screening, a single-center study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 6, 2020 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

‘It’s Insidious’: How Juul Pitched E-Cigs to Native American Tribes
New Congressional documents reveal that e-cigarette maker Juul Labs pitched its products to at least eight Native American tribes, in a move tribal health advocates say is as disturbing as it is expected. “I always suspected that the targeting of tribes was more pervasive than we knew,” says Rae O’Leary, a public health analyst who founded the anti-tobacco Canli Coalition of the Cheyenne River Sioux Tribe (CRST) and in July testified before Congress about Juul’s outreach to the CRST. “It’s saddening. The tobacco industry and the e-cigarette industry see us as a vulnerable population, one...
Source: TIME: Health - February 6, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized E-Cigarettes public health Source Type: news

Uptick in Lung Cancer in Younger Women, Not Related to Smoking Uptick in Lung Cancer in Younger Women, Not Related to Smoking
New data on lung cancer in younger adults ( (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 6, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lung cancer symptoms: Three signs in your face that could signal the deadly disease
LUNG cancer symptoms don't usually appear in the early stages and tend to develop as the condition progresses. Like all cancers, there's currently no cure, which is why spotting symptoms when they show is very important. There are three signs to look for in a person's face. (Source: Daily Express - Health)
Source: Daily Express - Health - February 6, 2020 Category: Consumer Health News Source Type: news

Variability in Information Content on Lung Cancer Screening Websites
Inconsistencies observed by researchers on these websites indicated that efforts are needed to improve website content and readability. (Source: CancerNetwork)
Source: CancerNetwork - February 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

'Fluorescent markers' to illuminate cancer begins Phase 3 clinical trials
(Purdue University) Purdue-discovered intraoperative molecular imaging used to illuminate and target non-small-cell lung cancer shows improved outcomes for 26% of patients in multi-institutional Phase 2 clinical trial, receives FDA fast track. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2020 Category: International Medicine & Public Health Source Type: news

Early and rapid diagnosis of lung cancer
GPs can play a critical role in the early diagnosis of lung cancer, according to the UK Lung Cancer Coalition. (Source: NHS Networks)
Source: NHS Networks - February 6, 2020 Category: UK Health Source Type: news

FDA Moves Closer to Standardized Testing for Asbestos in Talc
The U.S. Food and Drug Administration moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos fibers. Experts from eight different federal agencies explained earlier recommendations at a day-long hearing. The session also featured input from 25 members of the public, which included industry representatives, consumer advocates and testing experts. “Standards are needed,” said Dr. Paul Howard, FDA Office of Regulatory Science, during his presentation. “They just don’t exist at this time.” Dr. Linda Katz, director of the FDA Office of ...
Source: Asbestos and Mesothelioma News - February 5, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Lung Cancer Incidence Rates Up for Young Women Versus Men
Significant increases seen in female - to - male incidence rate ratios in six countries (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 5, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pulmonology, Journal, Source Type: news

Lung Cancer Incidence Rates Up for Young Women Versus Men
WEDNESDAY, Feb. 5, 2020 -- In recent years, a trend has emerged for higher lung cancer incidence rates among young women versus young men, and these findings are widespread across countries, according to a study published online Feb. 5 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2020 Category: Pharmaceuticals Source Type: news

USC scientists advance better imaging tool to study disease
(University of Southern California) USC scientists have developed a new tool to peer more deeply and clearly into living things so science can be used to develop better diagnostics and treatments, including detecting lung cancer or damage from pollutants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news

Lung cancer rates are rising in young women across multiple countries
(Wiley) An International Journal of Cancer study that examined lung cancer rates in young adults in 40 countries across five continents uncovered a trend of higher lung cancer rates in women compared with men in recent years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news

Patient Decision Aid Leads to Improved Decision-Making About Lung Cancer Screening
Delivering the PDA to clients of tobacco quit lines, researchers highlighted the importance of broader dissemination and greater effect of the intervention. (Source: CancerNetwork)
Source: CancerNetwork - February 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Inhibition of Pathway May Lead to Prevention and Treatment of NSCLC
Researchers found that through inheritable changes of gene expression, chronic exposure to IL-1 β can promote lung cancer metastasis, without altering DNA sequence. (Source: CancerNetwork)
Source: CancerNetwork - February 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Patient Decision Aid Informs Patients on Lung Cancer Screening
TUESDAY, Feb. 4, 2020 -- Use of a patient decision aid (PDA) results in more informed decisions about lung cancer screening compared with standard educational information (EDU), according to a study published online Jan. 31 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2020 Category: Pharmaceuticals Source Type: news

There is hope for a new test to diagnose early-stage lung cancer | Letters
Pauline ArmoryandMaxine Arnott write about a recently completed trial that has the potential to detect lung cancer with a blood testandProf Martin Marshallsays it wrong to blame GPs for failing to spot symptomsYou rightly report that one of the key reasons lung cancer is the biggest cause of cancer deaths in the UK is that up to 56% of lung cancers are only discovered in A&E where patients present with late-stage symptoms, by which point they often have only months to live (Report, 31 January).Every year in the UK around 40,000 people are diagnosed with lung cancer and 35,000 people die – it kills more women, for...
Source: Guardian Unlimited Science - February 4, 2020 Category: Science Authors: Letters Tags: Lung cancer NHS Cancer research Health Society Medical research Science Source Type: news

Rush Limbaugh announces lung cancer diagnosis
Conservative radio host Rush Limbaugh announced on his show that he has been diagnosed with "advanced lung cancer." He told his listeners he would be gone while undergoing treatment. Manuel Bojorquez reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 4, 2020 Category: Consumer Health News Source Type: news

Health Highlights: Feb. 4, 2020
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Rush Limbaugh Has Advanced Lung Cancer Rush Limbaugh revealed Monday that he has advanced lung cancer. On his live show, the 69-year-old... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 4, 2020 Category: General Medicine Source Type: news

Rush Limbaugh Has Advanced Lung Cancer
Title: Rush Limbaugh Has Advanced Lung CancerCategory: Health NewsCreated: 2/4/2020 12:00:00 AMLast Editorial Review: 2/4/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 4, 2020 Category: Cancer & Oncology Source Type: news

CT screening cuts lung cancer deaths in European men and women
(Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - February 4, 2020 Category: Consumer Health News Authors: Anna Fifield Source Type: news

Rush Limbaugh Reveals He Has Advanced Lung Cancer
The conservative radio talk show host said during a live radio broadcast on Monday that he would keep working, but would take some days off to work out a treatment plan. (Source: NYT Health)
Source: NYT Health - February 3, 2020 Category: Consumer Health News Authors: Jacey Fortin Tags: Limbaugh, Rush Radio Lung Cancer iHeartMedia Inc Source Type: news

United Therapeutics gets disappointing news on cancer therapy
United Therapeutics Corp. ’s (NASDAQ: UTHR) trial of one of its cancer therapies in small cell lung cancer did not achieve its goals, the company announced Monday. The Silver Spring company conducted a trial, called a DISTINCT study, of Unituxin in patients with some forms of small cell lung cancer, but said Monday that the therapy did not extend the overall survival of those patients.  Unituxin, or dinutuximab, first received approval from the Food and Drug Administration in March 2015 to treat… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 3, 2020 Category: Pharmaceuticals Authors: Rebecca Cooper Source Type: news